Licensing deals help Antisoma bolster UK biotech in full year results
This article was originally published in Scrip
Executive Summary
Antisoma posted a 9% increase in cash resources to £66.9 million in its year-end financial results to June 30th, which it believes is enough to last it until 2010. The company also posted revenues of £39.5 million, a significant increase from the same period last year, when Antisoma earned just £8 million.